Trickle Feed Rates for Continuous Enteral Nutrition
Start continuous enteral nutrition at 10–20 mL/hour in critically ill adults, increase by 25 mL/hour every 8 hours as tolerated, and monitor for abdominal distension, vomiting, or gastric residual volumes >200–500 mL/6 hours before each advancement. 1, 2
Initial Starting Rate
- Begin at 10–20 mL/hour for most critically ill patients, particularly those at risk for feeding intolerance 1
- Well-nourished patients without recent nutritional compromise may start at up to 50 mL/hour 2
- Post-surgical patients undergoing major abdominal procedures should start at the lower end (10 mL/hour maximum 20 mL/hour) due to limited intestinal tolerance 1
Titration Schedule
Standard advancement protocol:
- Increase by 25 mL/hour every 8 hours provided tolerance criteria are met 2
- This stepwise approach typically achieves target rates by day 5–7 1, 2
Example progression:
- Hours 0–8: 20 mL/hour
- Hours 8–16: 45 mL/hour
- Hours 16–24: 70 mL/hour
- Continue increasing by 25 mL/hour every 8 hours until goal rate achieved 2
Monitoring for Intolerance Before Each Rate Increase
Clinical Assessment (Primary)
Assess for these signs before advancing the rate:
- Abdominal pain or distension 1
- Vomiting 1, 3
- Increasing intra-abdominal pressure in patients with severe abdominal pathology 1
- New gastrointestinal symptoms 1
Gastric Residual Volume Monitoring
Current evidence-based thresholds:
- Check gastric residuals every 4 hours in patients with questionable GI motility 3, 4
- Delay rate advancement if GRV >200 mL and reassess feeding strategy 2, 3
- The ESICM guideline suggests delaying EN when GRV >500 mL/6 hours 1
- Consider that routine GRV monitoring may not be necessary in all patients, as recent evidence questions its impact on clinical outcomes 4, 5
Metabolic Monitoring (First 3–5 Days)
- Monitor electrolytes (sodium, potassium, magnesium, calcium, phosphate) closely to prevent refeeding syndrome 2
- This is particularly critical in severely malnourished patients 2
Management of Intolerance
If signs of intolerance develop:
- Do not advance the rate; continue at current slow rate or temporarily cease feeding depending on severity 1
- Use intravenous erythromycin (100–250 mg three times daily) as first-line prokinetic for 24–48 hours 1
- Alternative: metoclopramide (10 mg three times daily) or combination therapy 1
- Consider post-pyloric feeding if prokinetics fail and GRV remains elevated 1
Special Populations Requiring Slower Advancement
High-risk patients needing more cautious titration:
- Severely malnourished patients (heightened refeeding syndrome risk) 2
- Post-major surgery or multiorgan failure patients 2
- Patients with uncontrolled shock, hypoxemia, or acidosis (delay EN until stabilized) 1
- Those with bowel ischemia, obstruction, or abdominal compartment syndrome 1
Route-Specific Considerations
Gastric feeding:
- Tolerates higher rates and faster advancement 2
- Preferred initial route in COVID-19 and most critically ill patients 1
Jejunal/post-pyloric feeding:
- Start at 10 mL/hour with isotonic saline for first 24 hours 2
- Advance more gradually than gastric feeding 2
- Consider only after failed management of gastric intolerance due to staff exposure risk during tube insertion 1
Critical Safety Measures
- Maintain head-of-bed elevation ≥30 degrees continuously during feeding and for 30 minutes after to prevent aspiration 3
- Add food coloring to feedings to detect aspiration or tube displacement 6
- Flush feeding tubes with water every 4 hours during continuous feeding 6
- Avoid targeting full energy requirements in the early acute phase; hypocaloric feeding (not exceeding 70% of energy expenditure) may be safer 1
Common Pitfalls to Avoid
- Do not wait for bowel sounds before initiating or advancing feeds—this is outdated practice 7
- Do not aim for full caloric targets immediately; early overfeeding appears harmful 1
- Do not routinely check GRV in stable patients with normal GI function, as this may unnecessarily interrupt feeding 4, 5
- Do not continue advancing rates in the presence of new abdominal symptoms, even if GRV is acceptable 1